Asked by: David Davis (Conservative - Haltemprice and Howden)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what data sets will flow into the Federated Data Platform; and what her planned timetable is for each of those data sets to be (a) visible and (b) in use on the Federated Data Platform by participating hospital trusts.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
The NHS Federated Data Platform will deliver measurable improvements for patients. It will allow people to be discharged quicker, and for waiting lists to be shortened, through making better use of data.
It will securely bring together information already available to trusts, in hospital health records, waiting lists, and theatre and staff rosters, to better manage patient care. Each NHS organisation will be the data controller for their instance of the platform. Data will always remain under the full control and protection of the NHS and is only visible to approved users.
The NHS Federated Data Platform will provide trusts and integrated care boards, on behalf of local integrated care systems, with a set of core capabilities and nationally developed products, to support five key National Health Service priorities: elective recovery; care-co-ordination; vaccination and immunisation; population health management; and supply chain management.
A suite of products will sit under each of the use cases. A product is a software solution to address a particular NHS need, for example a patient discharge product which brings together data to help support discharge teams in hospitals in getting patients the right care in the right place. As each product is developed or transitioned to the NHS Federated Data Platform, a privacy notice will be published, setting out the data that will be utilised within the product. These are available at the following link:https://www.england.nhs.uk/contact-us/privacy-notice/how-we-use-your-information/nhs-federated-data-platform-privacy-notice/fdp-products-and-product-privacy-notices/
The NHS Federated Data Platform is being implemented in phases, with the first phase, from March to July 2024, being a transition of existing National Data Platform products to the national instance of the NHS Federated Data Platform, and the transition of 44 pilot sites to local instances. The second phase, from May 2024 to March 2027 and following the successful transition phase, is the rollout of instances of the platform to new trusts and integrated care boards. Once trusts and boards have their local instance of the platform, they can choose to use any of the nationally commissioned products, and develop new or additional products locally, to address local issues. This is when the data will become visible to approved users.
Asked by: Wes Streeting (Labour - Ilford North)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what estimate she has made of the number of repeat prescriptions that have been ordered through the NHS app in each of the last 12 months.
Answered by Andrea Leadsom - Parliamentary Under-Secretary (Department of Health and Social Care)
There are currently over 34.3 million sign-ups on the NHS App, enabling users to access a range of National Health Services, such as booking and managing general practice (GP) and hospital appointments, ordering repeat prescriptions, and viewing their prospective GP health record. The following table shows the number of repeat prescriptions ordered via the NHS App in each of the last 12 months, as well as the mean and total of repeat prescriptions:
Date | Repeat prescription orders via NHS App |
April 2023 | 2,449,182 |
May 2023 | 2,709,129 |
June 2023 | 2,650,714 |
July 2023 | 2,825,324 |
August 2023 | 2,885,337 |
September 2023 | 2,819,310 |
October 2023 | 3,105,964 |
November 2023 | 3,197,218 |
December 2023 | 3,124,667 |
January 2024 | 3,559,170 |
February 2024 | 3,349,017 |
March 2024 | 3,669,727 |
Mean | 3,028,730 |
Total | 36,344,759 |
Asked by: Julian Knight (Independent - Solihull)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how many people have registered for the NHS App since its creation.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
As of March 2024, there were 34.3 million sign-ups for the NHS App.
Asked by: Daisy Cooper (Liberal Democrat - St Albans)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether she plans to publish a response to the Patient Coalition for AI, Data and Digital Tech in Health's report entitled Public and Patient Experience of the NHS app, published on 27 March 2024, in the context of its recommendations on retaining (a) face-to-face and (b) telephone appointments.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
We recognise that digital skills levels are not universal, including amongst those people who need our health services the most. NHS England is therefore collaborating with local organisations and charities to include NHS App support in their outreach programmes. Alongside this, we have a priority programme to develop secure and safe ways for families and carers to access the NHS App on behalf of other people. The efficiency that the NHS App brings to frontline health services frees up staff to reach people who cannot access digital services via face-to-face and telephone appointments which will continue to be available.
The Department is not planning to publish a formal response to the report, but will use the recommendations to inform ongoing work to improve the App.
People can currently log in to the NHS App with their face ID or fingerprint and can be remembered on their device too. We are introducing more automated ID checks and new forms of login in the next 6 months, to make it even quicker for people to register and log in to the NHS App across a range of devices. This includes our web version that people without smartphones can access.
In the short term, we are making it easier to read information in the medical record, appointment lists, test results and prescription information. NHS England is making strategic changes in how the data is sent from system suppliers which will allow it to be more clearly presented.
We are updating plans to help frontline staff support their patients to use the NHS App, through training and support. This will be backed up by improvements to existing help pages and support processes and redesigning the contact form to make sure queries can be quickly resolved.
NHS England will work closely with frontline staff, Patient Participation Groups and our large App Ambassador network so that they can explain the NHS App to patients. This network will be expanded so that awareness of the support offer is raised further as suggested in the report.
Asked by: Daisy Cooper (Liberal Democrat - St Albans)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment she has made of the potential implications for her policies of the Patient Coalition for AI, Data and Digital Tech in Health report entitled Public and Patient Experience of the NHS app, published on 27 March 2024.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
We recognise that digital skills levels are not universal, including amongst those people who need our health services the most. NHS England is therefore collaborating with local organisations and charities to include NHS App support in their outreach programmes. Alongside this, we have a priority programme to develop secure and safe ways for families and carers to access the NHS App on behalf of other people. The efficiency that the NHS App brings to frontline health services frees up staff to reach people who cannot access digital services via face-to-face and telephone appointments which will continue to be available.
The Department is not planning to publish a formal response to the report, but will use the recommendations to inform ongoing work to improve the App.
People can currently log in to the NHS App with their face ID or fingerprint and can be remembered on their device too. We are introducing more automated ID checks and new forms of login in the next 6 months, to make it even quicker for people to register and log in to the NHS App across a range of devices. This includes our web version that people without smartphones can access.
In the short term, we are making it easier to read information in the medical record, appointment lists, test results and prescription information. NHS England is making strategic changes in how the data is sent from system suppliers which will allow it to be more clearly presented.
We are updating plans to help frontline staff support their patients to use the NHS App, through training and support. This will be backed up by improvements to existing help pages and support processes and redesigning the contact form to make sure queries can be quickly resolved.
NHS England will work closely with frontline staff, Patient Participation Groups and our large App Ambassador network so that they can explain the NHS App to patients. This network will be expanded so that awareness of the support offer is raised further as suggested in the report.
Asked by: Navendu Mishra (Labour - Stockport)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what progress the Medical Devices Outcome Registry Programme has made on centralising NHS England clinical registries.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
The Medical Device Outcome Registry, National Joint Registry, and National Vascular Registry have been incorporated into a central software platform. Registries for ongoing migration are the legacy NHS Digital Breast and Cosmetic Implant Registry, and the Pelvic Organ Prolapse and Stress Urinary Incontinence Registries. The National Registry of Hearing Implants (Cochlear) and National Major Trauma Registry are new registries in development. As of 26 March 2024, 69 providers have been onboarded to the Medical Device Outcome Registry.
Asked by: Navendu Mishra (Labour - Stockport)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, which of the 37 established NHS clinical registries have been incorporated onto a central software platform.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
The Medical Device Outcome Registry, National Joint Registry, and National Vascular Registry have been incorporated into a central software platform. Registries for ongoing migration are the legacy NHS Digital Breast and Cosmetic Implant Registry, and the Pelvic Organ Prolapse and Stress Urinary Incontinence Registries. The National Registry of Hearing Implants (Cochlear) and National Major Trauma Registry are new registries in development. As of 26 March 2024, 69 providers have been onboarded to the Medical Device Outcome Registry.
Asked by: Navendu Mishra (Labour - Stockport)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how much his Department has spent on contracts with NEC Software Solutions for centralising existing clinical registries.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
The current contract with NEC Software Solutions for centralising the Medical Device Outcome Registry, National Joint Registry, and National Vascular Registry is £969,544. Further information is available at the GOV.UK contracts finder, at the following link:
https://www.contractsfinder.service.gov.uk/Notice/bb2b90d1-c52c-4388-9159-7e8b8dce3c32
Asked by: Lord Bishop of St Albans (Bishops - Bishops)
Question to the Department of Health and Social Care:
To ask His Majesty's Government what plans they have to expand public awareness campaigns for prostate cancer, following the prediction by the Lancet Commission of a surge in cases.
Answered by Lord Markham - Parliamentary Under-Secretary (Department of Health and Social Care)
Prostate cancer is the most common cancer in men in the United Kingdom, and currently has no screening programme. The recently announced TRANSFORM trial aims to find the best way to screen for prostate cancer. This study is led by Prostate Cancer UK and supported by £42 million of Government funding.
In March 2024, NHS England implemented the Faster Diagnosis Standard (FDS), setting a target of a maximum 28 day wait from urgent suspected general practice or screening referral to patients being told they have cancer, or that cancer is ruled out. To achieve this target, NHS England is streamlining cancer pathways by introducing best-practice timed pathways for prostate cancer, so that those suspected of having prostate cancer receive a multi-parametric magnetic resonance imaging scan first, which ensures only those men most at risk of having cancer undergo an invasive biopsy. As well as diagnosing patients faster, NHS England is working to diagnose patients at an earlier stage, through the ambitions set out in the NHS Long-Term Plan, to diagnose 75% of cancers at stages one and two by 2028.
NHS England takes steps to raise awareness of prostate cancer, where there are opportunities to do so. For example, NHS England partners with Cancer Alliances, charities, and local representatives to reach people through projects in the heart of their communities. Cancer Alliances have also been undertaking action to alert at-risk groups about prostate cancer. This is determined at a local level, and so will vary depending on local needs and priorities.
The Government has made significant strides in enabling the use of artificial intelligence (AI) systems to support the diagnosis of many types of cancer, including prostate. The AI in Health and Care Award was established, aiming to accelerate the testing and development of AI technologies that align with the NHS Long Term Plan. The award represents a substantial investment in the future of healthcare technology, with £113 million already allocated to support 86 AI technologies. Three of these projects specifically relate to prostate cancer, one of which is the Paige prostate cancer detection tool, developed by the University of Oxford. This AI-based diagnostic software aids in the interpretation of pathology sample images, facilitating more efficient detection, grading, and quantification of cancer in prostate biopsies. The Chancellor’s recent budget announcement on 6 March 2024 includes a £3.4 billion investment to reform how the National Health Service works, including on the use of technologies such as AI.
Finally, although no specific assessment of the Lancet Commission published 4 April 2024 has been made, the Department will work with NHS England to review the details.
Asked by: Lord Bishop of St Albans (Bishops - Bishops)
Question to the Department of Health and Social Care:
To ask His Majesty's Government, what plans they have to use artificial intelligence systems to support the diagnosis of prostate cancer, as recommended by the Lancet Commission in research published on 4 April.
Answered by Lord Markham - Parliamentary Under-Secretary (Department of Health and Social Care)
Prostate cancer is the most common cancer in men in the United Kingdom, and currently has no screening programme. The recently announced TRANSFORM trial aims to find the best way to screen for prostate cancer. This study is led by Prostate Cancer UK and supported by £42 million of Government funding.
In March 2024, NHS England implemented the Faster Diagnosis Standard (FDS), setting a target of a maximum 28 day wait from urgent suspected general practice or screening referral to patients being told they have cancer, or that cancer is ruled out. To achieve this target, NHS England is streamlining cancer pathways by introducing best-practice timed pathways for prostate cancer, so that those suspected of having prostate cancer receive a multi-parametric magnetic resonance imaging scan first, which ensures only those men most at risk of having cancer undergo an invasive biopsy. As well as diagnosing patients faster, NHS England is working to diagnose patients at an earlier stage, through the ambitions set out in the NHS Long-Term Plan, to diagnose 75% of cancers at stages one and two by 2028.
NHS England takes steps to raise awareness of prostate cancer, where there are opportunities to do so. For example, NHS England partners with Cancer Alliances, charities, and local representatives to reach people through projects in the heart of their communities. Cancer Alliances have also been undertaking action to alert at-risk groups about prostate cancer. This is determined at a local level, and so will vary depending on local needs and priorities.
The Government has made significant strides in enabling the use of artificial intelligence (AI) systems to support the diagnosis of many types of cancer, including prostate. The AI in Health and Care Award was established, aiming to accelerate the testing and development of AI technologies that align with the NHS Long Term Plan. The award represents a substantial investment in the future of healthcare technology, with £113 million already allocated to support 86 AI technologies. Three of these projects specifically relate to prostate cancer, one of which is the Paige prostate cancer detection tool, developed by the University of Oxford. This AI-based diagnostic software aids in the interpretation of pathology sample images, facilitating more efficient detection, grading, and quantification of cancer in prostate biopsies. The Chancellor’s recent budget announcement on 6 March 2024 includes a £3.4 billion investment to reform how the National Health Service works, including on the use of technologies such as AI.
Finally, although no specific assessment of the Lancet Commission published 4 April 2024 has been made, the Department will work with NHS England to review the details.